Windlas Biotech Ltd

Past performance
Performance overview
Windlas Biotech Ltd
About Windlas Biotech Ltd Windlas Biotech Limited, established in 2001, is a pharmaceutical company based in Dehradun, Uttarakhand. Transitioning from a private to a public entity in April 2021, the company manufactures and trades pharmaceutical, nutraceutical, and Ayurvedic products, targeting semi-urban and rural markets with affordable solutions. Windlas Biotech operates across three strategic business verticals: CDMO services, domestic trade generics, OTC brands, and exports. Their Dehradun facilities, operational since 2010, are GMP-compliant, focusing on product discovery, development, and manufacturing of complex generic drugs, often involving advanced drug-device combinations. The company emphasizes innovation and quality throughout the product lifecycle, from R&D to customer evaluation. Their expertise in developing complex generics includes fixed dosage combinations and customized generics, requiring specialized processes. In 2021, they raised Rs 401.53 Crore through an IPO to support growth initiatives. Windlas Biotech's robust vendor assessment ensures consistent quality, efficacy, and safety of its products, bolstering its position in the pharmaceutical industry.
Website windlasbiotech.com
Founded 2001
Headquarters Dehradun